Author

K. Nie

Icahn School of Medicine at Mount Sinai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

B. Lee· 2 shared S. Kim-Schulze· 2 shared A. Charney· 1 shared A. Demetriou· 1 shared A. H. Rahman· 1 shared A. Narasimhan· 1 shared A. Rangel· 1 shared A. Tabachnikova· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. Lee

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

The HLA-E/NKG2A axis identifies a therapeutic vulnerability in BCG-unresponsive bladder cancer

Bérengère Salomé, Haocheng Yu, Daniel L Ranti, Ying‐Chih Wang, C. Bieber, Pierre‐Etienne Gabriel, Igor Duquesne, Trine Strandgaard, B. Hug, Sean Houghton, Hiranmayi Ravichandran, Elliot Merritt, S. Bang, A. Demetriou, Z. Li, , Amir Horowitz

This study identifies the HLA-E/NKG2A axis as a therapeutic target in BCG-unresponsive bladder cancer by showing its role in immune evasion and impaired effector cell function.

bioRxiv · Sep 2, 2024 · PreprintCancer Biology

Shift of lung macrophage composition is associated with COVID-19 disease severity and recovery

S. T. Chen, M. D. Park, D. M. Del Valle, M. Buckup, A. Tabachnikova, N. W. Simons, K. Mouskas, B. Lee, D. Geanon, D. D'Souza, T. Dawson, R. Marvin, K. Nie, R. Thompson, Z. Zhao, , M. Merad

This study identifies shifts in lung macrophage composition linked to COVID-19 severity and recovery, suggesting therapeutic strategies targeting macrophage function.

bioRxiv · Jan 11, 2022 · PreprintImmunology

An Antioxidant Enzyme Therapeutic for COVID-19

M. Qin, Z. Cao, J. Wen, Q. Yu, C. Liu, F. Wang, F. Yang, Y. Li, G. A. Fishbein, S. Yan, B. Xu, Y. Hou, Z. Ning, K. Nie, N. Jiang, , Y. Lu

This paper describes a catalase-based therapeutic for COVID-19 that reduces oxidative stress and cytokine production in human and animal models without toxicity.

bioRxiv · Jul 15, 2020Biochemistry

Performance of bitumen coating sheet using biomass pyrolysis oil

Y. Ren, L. Zhang, W. Duan, Z. Han, J. Guo, M. D. Heydenrych, A. Zhang, K. Nie, T. Tan, L. Liu

This study evaluates bio-bitumen made from biomass pyrolysis oil as a substitute for petro-bitumen in coating sheets, showing improved adhesion, temperature stability, mechanical strength, and flexibility.

bioRxiv · Apr 2, 2019Bioengineering